Cynthia Rice
Nurse Practitioner · Pocatello, IDNPI 1427041763
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,564 of the $2,995 with a category attached, or 85.6%. 17 manufacturers reported payments, led by AbbVie at 26.3% of the total. Among nurse practitioner clinicians in ID with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 126 payments — averaging $23.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$789
- Inspire Medical Systems, Inc.$384
- Harmony Biosciences LLC$318
- Jazz Pharmaceuticals Inc.$279
- Novo Nordisk$260
- AstraZeneca$254
- plus $711 from 11 others
What the payments were for
- Food & beverage$2,56486%
- Education$43214%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 37 | $789 |
| Inspire Medical Systems, Inc. | 17 | $384 |
| Harmony Biosciences LLC | 12 | $318 |
| Jazz Pharmaceuticals Inc. | 7 | $279 |
| Novo Nordisk | 11 | $260 |
| AstraZeneca | 10 | $254 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $148 |
| Axsome Therapeutics, Inc. | 8 | $145 |
| Lilly USA, LLC | 7 | $110 |
| Teva Pharmaceuticals USA, Inc. | 2 | $109 |
| ZOLL Respicardia, Inc. | 2 | $54 |
| Eisai Inc. | 1 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Biohaven Pharmaceuticals, Inc. | 2 | $29 |
| Itamar Medical Inc | 1 | $17 |
| Impel Pharmaceuticals Inc. | 1 | $12 |
| Amgen | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$107
How this compares
$2,995 in reported general payments places this provider in the 90th percentile of 570 nurse practitioner providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 58 | $76,628 |
| Xigduo XrDapaglifloz Propaned/Metformin | 24 | $18,802 |
| Bydureon BciseExenatide Microspheres | 13 | $8,991 |
| Naltrexone Hcl | 19 | $1,105 |
| Ropinirole Hcl | 54 | $1,095 |
| Quetiapine Fumarate | 38 | $1,029 |
| Bupropion XlBupropion Hcl | 25 | $717 |
| Topiramate | 67 | $694 |
| Modafinil | 21 | $619 |
| Levothyroxine Sodium | 26 | $609 |
| Trazodone Hcl | 45 | $555 |
| Gabapentin | 13 | $452 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $363 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 28 | $318 |
| Metformin Hcl ErMetformin Hcl | 30 | $216 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $260 | $76,62858 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 570 nurse practitioner providers in Idaho.
Other nurse practitioner in Pocatello
- Hanna PercyPocatello$6K
- Ronda EdgleyPocatello$3K
- Kathleen CliffordBoise$119K
- Alissa HelvikCoeur D Alene$93K
- Amanda ThompsonIdaho Falls$67K
- Micalena PerkinsBurley$44K
- Tosha JohnsonNampa$26K
- Loreen NugentBoise$20K
- Rachel RyanMeridian$19K
- Stephanie HartPost Falls$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.